BioMarin Pharmaceutical, Inc.
(NASDAQ : BMRN)

( )
BMRN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -16.36%57.710.0%$1498.86m
GILDGilead Sciences, Inc. -0.22%73.181.0%$1307.19m
AMGNAmgen, Inc. -1.78%222.401.3%$642.71m
NVAXNovavax, Inc. 4.47%48.17102.0%$586.24m
REGNRegeneron Pharmaceuticals, Inc. -4.33%545.212.5%$546.52m
VRTXVertex Pharmaceuticals, Inc. -6.48%266.501.9%$495.73m
BIIBBiogen, Inc. -2.84%295.871.6%$409.33m
ILMNIllumina, Inc. -0.08%354.413.5%$346.51m
SRNESorrento Therapeutics, Inc. 3.95%5.271.8%$307.12m
SGENSeattle Genetics, Inc. -2.59%151.736.1%$229.36m
ALXNAlexion Pharmaceuticals, Inc. 1.28%102.802.0%$224.52m
CODXCo-Diagnostics, Inc. -2.80%18.030.0%$192.65m
AAgilent Technologies, Inc. 1.37%86.141.6%$192.54m
MGNXMacroGenics, Inc. -6.82%23.646.2%$185.80m
BMRNBioMarin Pharmaceutical, Inc. 6.39%103.744.3%$158.47m

Company Profile

BioMarin Pharmaceutical, Inc. is a biotechnology company, which engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline include Vosoritide (BMN 111) for Achondroplasia and Valoctocogene Roxaparvovec (BMN 270) for Hemophilia A. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.